Table 1.
Visit Numbera | V1 | V2 | V3 | V4 | V5 | V6 | V7 | V8 | V9 | V10 | V11 | V12 | V13 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eligibility assessment | X | ||||||||||||
Baseline H&P | X | ||||||||||||
Follow-up H&P | X | X | X | X | X | X | X | X | X | X | |||
Biosample baseline | X | ||||||||||||
Biosample follow-up | X | X | X | X | X | X | X | X | X | X | |||
24-hour urine | X | X | X | X | X | X | X | X | |||||
Clean catch/(Spot) urine | X | X | X | X | X | X | X | X | X | X | X | ||
Renal biopsy tissue | Xb |
Abbreviations: H&P history and physical examination, UA urinalysis, macroscopic (color, appearance, specific gravity, pH, leukocyte esterase, nitrite, protein, glucose, ketones, urobilin, bilirubin, blood), V visit
aThere will be a total of 13 visits for the anticipated 600 participants in the study. In each visit, a total of 11 tubes will be generated (3 of 5 mL tubes, 7 of 2 mL tubes and 1 of 50 mL tube)
bRenal biopsy includes a pre-biopsy 10 mL spot urine